Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~24 mi. (Villingen-Schwenningen, Germany, +94 more cities)

Schwarzwald-Baar-Klinikum

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML

~30 mi. (Gutach im Breisgau, Germany, +74 more cities)

Universitaetsklinikum Freiburg

Acute Myeloid Leukemia, +4 more conditions

decitabine, +1 more drug

chemotherapy

Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)

~37 mi. (Eßlingen, Germany, +145 more cities)

Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1208)

Non-Small Cell Lung Carcinoma

pembrolizumab, +1 more drug

immunotherapy, +2 more types

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~44 mi. (Freiburg, Germany, +226 more cities)

Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

~44 mi. (Freiburg, Germany, +140 more cities)

Universitaetsklinikum Freiburg ( Site 0199)

Hepatocellular Carcinoma

lenvatinib, +2 more drugs

chemotherapy, +2 more types

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~44 mi. (Freiburg, Germany, +93 more cities)

Universitaetsklinikum Freiburg ( Site 0512)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

~44 mi. (Freiburg, Germany, +93 more cities)

Klinik fuer Urologie ( Site 1303)

Clear Cell Renal Cell Carcinoma

belzutifan, +1 more drug

targeted therapy

Futibatinib in Patients With Specific FGFR Aberrations

~44 mi. (Freiburg, Germany, +53 more cities)

Universitaetsklinikum Freiburg

FGFR1 Fusion, +4 more biomarkers

Adenocarcinoma of the Gastroesophageal Junction, +4 more conditions

futibatinib

targeted therapy

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

~44 mi. (Freiburg, Germany, +53 more cities)

Universitätsklinikum Freiburg

Desmoplastic Small Round Cell Tumor

cyclophosphamide, +2 more drugs

chemotherapy, +1 more type

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

~44 mi. (Freiburg, Germany, +42 more cities)

Universitaetsklinikum Freiburg /ID# 222791

Chronic Myelomonocytic Leukemia, +3 more conditions

celecoxib, +2 more drugs

Other, +1 more type

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

~44 mi. (Freiburg, Germany, +29 more cities)

Universitaetsklinikum Freiburg /ID# 164206

Cancer

chemotherapy, +1 more drug

chemotherapy

A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

~44 mi. (Freiburg, Germany, +16 more cities)

Site DE49002

FLT3 ITD

Acute Myeloid Leukemia

cytarabine, +3 more drugs

chemotherapy, +2 more types